Healthcare Global Enterprises

With substantial deleveraging of balance sheet, reduction in losses across new centers, and focus on free cash flow generation,…

20 per cent growth in FY2022 revenues expected, expected to go slow on capex to conserve cash and focus on better utilisation of…

Based on the comprehensive genomic profiling approach which detects multiple actionable cancer biomarkers at ‘one go’ to optimise…

The 105 bedded centre will provide comprehensive diagnosis, radiation, medical and surgical oncology services under one roof

Lumos Health, a market access programme launched by Anthill Ventures and HealthCare Global Enterprises (HCG) for health start-ups,…

The market access programme will help selected start-ups achieve scale and raise investments Anthill Ventures, an investment…

Experts put their views forward on Interim Budget 2019

Health industry experts urge the government on healthcare spending and ensure increased access

Fresh issue of up to 11.6 million equity shares, offer for Sale of up to 18.2 million equity shares HealthCare Global Enterprises…

With VABB technology, the biopsy for these small lesions can now be performed under the mammographic, stereotactic and ultrasound…